Prelude Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,053
| Closed | -$98K | – | 1235 |
|
|
2023
Q1 | $98K | Sell |
15,053
-1,436
| -9% | -$9.35K | 0.01% | 856 |
|
|
2022
Q4 | $141K | Sell |
16,489
-3,205
| -16% | -$27.3K | 0.01% | 888 |
|
|
2022
Q3 | $104K | Sell |
19,694
-22,006
| -53% | -$116K | ﹤0.01% | 1125 |
|
|
2022
Q2 | $177K | Buy |
41,700
+7,700
| +23% | +$32.7K | 0.01% | 1119 |
|
|
2022
Q1 | $119K | Buy |
34,000
+17,300
| +104% | +$60.6K | ﹤0.01% | 1090 |
|
|
2021
Q4 | $111K | Buy |
+16,700
| New | +$111K | ﹤0.01% | 1332 |
|